Development and Validation of a Stability-Indicating HPTLC Method for Analysis of Rasagiline Mesylate in the Bulk Drug and Tablet Dosage Form

Figure 6

Densitogram of hydrogen peroxide (30% v/v, reflux for 4 h, temp 80°C) treated rasagiline mesylate; peak 1 (degraded—𝑅_𝑓=0.43), peak 2 (degraded—𝑅_𝑓=0.53), peak 3 (degraded—𝑅_𝑓=0.68), and peak 4 (rasagiline mesylate—𝑅_𝑓=0.76).